Dissecting the Pathogenesis of the Severe Neurodegenerative Disease, Friedreich’s Ataxia: Development of Novel Therapeutics

Funding Activity

Website
http://purl.org/au-research/grants/nhmrc/1074033

Funding Status
Closed

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Friedreich’s ataxia is a devastating neuro- and cardio-degenerative disorder which does not have an effective cure. The studies proposed in this Fellowship are crucial for understanding the progression of this disorder and the development of excitingly new therapeutics.

Funded Activity Details

Start Date: 01-01-2014

End Date: 01-01-2017

Funding Scheme: Early Career Fellowships

Funding Amount: $316,449.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Pharmacology and Pharmaceutical Sciences not elsewhere classified

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

ataxia | cardiomyopathy | mitochondria | neurodegeneration | pharmaceutical treatment

Related Links